332 related articles for article (PubMed ID: 17297474)
1. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.
Narla G; Kremer-Tal S; Matsumoto N; Zhao X; Yao S; Kelley K; Tarocchi M; Friedman SL
Oncogene; 2007 Jun; 26(30):4428-34. PubMed ID: 17297474
[TBL] [Abstract][Full Text] [Related]
2. The role of KLF6 and its splice variants in cancer therapy.
DiFeo A; Martignetti JA; Narla G
Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
[TBL] [Abstract][Full Text] [Related]
3. Biology of Krüppel-like factor 6 transcriptional regulator in cell life and death.
Andreoli V; Gehrau RC; Bocco JL
IUBMB Life; 2010 Dec; 62(12):896-905. PubMed ID: 21154818
[TBL] [Abstract][Full Text] [Related]
4. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
5. KLF6, a candidate tumor suppressor gene mutated in prostate cancer.
Narla G; Heath KE; Reeves HL; Li D; Giono LE; Kimmelman AC; Glucksman MJ; Narla J; Eng FJ; Chan AM; Ferrari AC; Martignetti JA; Friedman SL
Science; 2001 Dec; 294(5551):2563-6. PubMed ID: 11752579
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas.
Pan XC; Chen Z; Chen F; Chen XH; Jin HY; Xu XY
J Zhejiang Univ Sci B; 2006 Oct; 7(10):830-6. PubMed ID: 16972326
[TBL] [Abstract][Full Text] [Related]
7. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
[TBL] [Abstract][Full Text] [Related]
8. Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma.
Kremer-Tal S; Reeves HL; Narla G; Thung SN; Schwartz M; Difeo A; Katz A; Bruix J; Bioulac-Sage P; Martignetti JA; Friedman SL
Hepatology; 2004 Nov; 40(5):1047-52. PubMed ID: 15486921
[TBL] [Abstract][Full Text] [Related]
9. [A candidate tumor suppressor gene mutated in primary hepatocellular carcinoma: kruppel-like factor 6].
Wang SP; Chen XP; Qiu FZ
Zhonghua Wai Ke Za Zhi; 2004 Oct; 42(20):1258-61. PubMed ID: 15598377
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.
Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL
Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706
[TBL] [Abstract][Full Text] [Related]
11. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
Narla G; DiFeo A; Yao S; Banno A; Hod E; Reeves HL; Qiao RF; Camacho-Vanegas O; Levine A; Kirschenbaum A; Chan AM; Friedman SL; Martignetti JA
Cancer Res; 2005 Jul; 65(13):5761-8. PubMed ID: 15994951
[TBL] [Abstract][Full Text] [Related]
12. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
[TBL] [Abstract][Full Text] [Related]
13. KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis.
Sirach E; Bureau C; Péron JM; Pradayrol L; Vinel JP; Buscail L; Cordelier P
Cell Death Differ; 2007 Jun; 14(6):1202-10. PubMed ID: 17347668
[TBL] [Abstract][Full Text] [Related]
14. Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma.
Song J; Kim CJ; Cho YG; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
J Gastroenterol Hepatol; 2006 Aug; 21(8):1286-9. PubMed ID: 16872311
[TBL] [Abstract][Full Text] [Related]
15. Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination.
DiFeo A; Narla G; Hirshfeld J; Camacho-Vanegas O; Narla J; Rose SL; Kalir T; Yao S; Levine A; Birrer MJ; Bonome T; Friedman SL; Buller RE; Martignetti JA
Clin Cancer Res; 2006 Jun; 12(12):3730-9. PubMed ID: 16778100
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor.
DiFeo A; Narla G; Camacho-Vanegas O; Nishio H; Rose SL; Buller RE; Friedman SL; Walsh MJ; Martignetti JA
Oncogene; 2006 Sep; 25(44):6026-31. PubMed ID: 16702959
[TBL] [Abstract][Full Text] [Related]
17. Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.
Yea S; Narla G; Zhao X; Garg R; Tal-Kremer S; Hod E; Villanueva A; Loke J; Tarocchi M; Akita K; Shirasawa S; Sasazuki T; Martignetti JA; Llovet JM; Friedman SL
Gastroenterology; 2008 May; 134(5):1521-31. PubMed ID: 18471523
[TBL] [Abstract][Full Text] [Related]
18. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
Moriyama Y; Nishiguchi S; Tamori A; Koh N; Yano Y; Kubo S; Hirohashi K; Otani S
Clin Cancer Res; 2001 May; 7(5):1293-8. PubMed ID: 11350897
[TBL] [Abstract][Full Text] [Related]
19. New candidate tumor-suppressor gene KLF6 and its splice variant KLF6 SV2 counterbalancing expression in primary hepatocarcinoma.
Zhenzhen Z; De'an T; Limin X; Wei Y; Min L
Hepatogastroenterology; 2012; 59(114):473-6. PubMed ID: 21940380
[TBL] [Abstract][Full Text] [Related]
20. Absence of mutation in the putative tumor-suppressor gene KLF6 in colorectal cancers.
Lièvre A; Landi B; Côté JF; Veyrie N; Zucman-Rossi J; Berger A; Laurent-Puig P
Oncogene; 2005 Nov; 24(48):7253-6. PubMed ID: 16044160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]